发明名称 |
COMBINATION COMPRISING AN AT1-RECEPTOR ANTAGONIST AND AN INSULIN SECRETION ENHANCER OR AN INSULIN SENSITISER |
摘要 |
THE PRESENT INVENTION RELATES TO A COMBINATION, ESPECIALLY A PHARMACEUTICAL COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS (I) AN AT 1-RECEPTOR ANTAGONIST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; (II) (A) AN INSULIN SECRETION ENHANCER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF OR (B) AN INSULIN SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AND, IN CASE OF A PHARMACEUTICAL COMPOSITION, A PHARMACEUTICALLYACCEPTABLE CARRIER.
|
申请公布号 |
MY141012(A) |
申请公布日期 |
2010.02.25 |
申请号 |
MYPI20013925 |
申请日期 |
2001.08.21 |
申请人 |
NOVARTIS AG |
发明人 |
MALCOLM ALLISON;MARJORIE REGAN GATLIN |
分类号 |
A61K31/41;A61K31/155;A61K31/198;A61K31/415;A61K31/4178;A61K31/4184;A61K31/4196;A61K31/426;A61K31/433;A61K31/4453;A61K31/505;A61K31/522;A61K31/64;A61K45/06;A61P1/04;A61P3/10;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P15/00;A61P15/10;A61P25/00;A61P27/12 |
主分类号 |
A61K31/41 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|